Benchmark Holdings plc (BHCCF)
Benchmark Holdings plc operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Sheffield, SY, GB. The stock last traded at $0.37, up 0.00% on the session, giving a market capitalisation of $225.1M. On trailing twelve-month figures it carries a trailing P/E of -4.13, a net margin of -43.7%. Its beta of 0.04 implies it has historically moved less than the broad market.
Benchmark Holdings plc, alongside its various subsidiaries, offers specialized technical services, innovative products, and expert knowledge designed to bolster the progress of food and farming industries worldwide. The company maintains a significant global presence, with operations spanning the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, and other parts of Europe. Benchmark structures its business through three primary segments: Genetics, Advanced Nutrition, and Health. Its Genetics division focuses on providing cutting-edge salmon breeding technologies and production infrastructure to deliver genetically superior ova, primarily for the aquaculture sector. The Advanced Nutrition segment is responsible for manufacturing and distributing crucial nutritional and health-enhancing products tailored specifically for the aquaculture industry. Furthermore, the Health segment supplies a range of dedicated health solutions to the aquatic farming market. Benchmark Holdings plc was established in 2000 and is headquartered in Sheffield, United Kingdom.
Benchmark Holdings plc is most often compared with the following Healthcare names: